Fostemsavir: New Option for Heavily Treatment Experienced (HTE) People Living with HIV-1 in Mexico
Doi.org/10.57594/1055 Reynaga Cristhian1*, Prakash Manyu2, Prudente Isidoro2 1GlaxoSmithKline, Mexico 2ViiV Healthcare, Brentford, United Kingdom *Autor de correspondencia: Reynaga Ortega Cristhian Daniel [email protected] Teléfono 55 4186 3911 Abstract: Antiretroviral therapy has been shown to effectively suppress viral replication, with a progressive improvement of the safety and…